Our executive team brings proven experience and expertise in developing and commercializing innovative nuclear medicine products and technologies.
Bio: Steve, appointed as President and Chief Executive Officer of NorthStar in September 2018, has more than 25 years of experience in the biotechnology, pharmaceutical and life sciences industries. He has held multiple executive positions with leading multinational companies, including leadership of nuclear medicine businesses. Steve has extensive general management and corporate officer experience, and a proven record of accomplishment with integrating science, engineering and commercial activities to drive complex projects to successful completion. Steve also served in the Royal Navy as a Nuclear Submarine Officer, where he specialized in Navigation and Operations.
Education: Steve received a BSc (Honors) in Engineering Science from the University of Exeter and an MBA from the London Business School, both in the United Kingdom. He also completed the Nuclear General Course at the Royal Naval Staff College, Greenwich in the United Kingdom.
Bio: Paul brings more than 30 years of relevant experience to NorthStar where he is responsible for the Financial operations of the company. Prior to NorthStar, he was the CFO of Melinta Therapeutics, Inc., a publicly traded company focused on the discovery, development and commercialization of novel antibiotics. During his five-year tenure at Melinta, Paul guided the company in the process of converting from a private to public enterprise, raised more than $500 million in support of the company, assisted in the acquisition of products from other companies, facilitated a merger and supported the commercial launch of multiple products. Prior to Melinta, he spent more than 20 years with Baxter International, Inc. where he held both financial and non-financial positions of increasing responsibility. During his tenure at Baxter, his experiences included divisional CFO for various divisions of Baxter, CFO of Baxter’s operations in Japan and serving as the Vice-President of Integration for a large acquisition. Prior to Baxter, Paul was a public accountant with Arthur Andersen & Co.
Education: Paul earned a Master of Business Administration degree from the Kellogg School of Management at Northwestern University and a Bachelor of Science degree in Accounting from Illinois State University.
Bio: Jim has more than 40 years of design and management experience in the areas of scientific development and business operations. His operational responsibilities have included leadership of laboratory operations in nuclear and mixed waste areas and environmental services. While involved in technology start-up companies, Jim has also been responsible for manufacturing, developing quality assurance programs for compliance to Nuclear Regulatory Commission and Department of Energy requirements, managing company activities to ensure compliance with federal and state regulations, and managing major government contracts involving federal research and development programs. He also served as a commissioned officer in the US Air Force in control of ballistic missiles, and has invented or co-invented several patented technologies.
Education: Jim received a BS in Chemistry from the University of Virginia and a Ph.D. in Nuclear Chemistry from the University of Arkansas.
Bio: Frank, appointed as NorthStar’s Chief Operating Officer in June 2021, has more than 20 years of global experience in the pharmaceutical and life sciences industries as well as in consulting. He has held executive-level positions in general management, operations, quality, alliance management, and merger integration. Frank has led transformative change throughout the value chain of pharmaceutical companies, and managed multiple acquisitions and divestitures in branded pharmaceuticals, generics, and medical device assets. Before joining NorthStar, Frank was a Managing Director with AlixPartners, the Chief Operations Officer and Chief Digital Innovation Officer at Mallinckrodt Pharmaceuticals, and a partner with McKinsey & Company.
Education: Frank holds a Ph.D. in Business Management from the University of Bielefeld, Germany, an MBA from the Georgetown University McDonough School of Business in Washington D.C., and a Master’s in Economics from the Leibniz University of Hannover, Germany.
Bio: Adrienne brings 15 years of Human Resources experience to NorthStar where she leads all Human Resources functions. Prior to joining NorthStar, she worked in Human Resources at Data Dimensions, a company providing Business Process Outsourcing solutions, supporting the organization through rapid growth and an acquisition. Prior to Data Dimensions, Adrienne was a Human Resources Generalist at Bourns Automotive Division where she supported the company through an acquisition and held responsibilities in recruiting, training, and benefits administration. Her comprehensive skill set in all aspects of Human Resources provides a valuable resource for NorthStar.
Education: Adrienne earned her BBA in Human Resources Management from the University of Wisconsin – Whitewater. In addition, she holds PHR and SHRM-CP certifications.
Bio: Barb brings 20 years’ experience with development and manufacturing of Class II medical devices along with 15 years’ experience in project and program management. Her technical experience started with roles in quality assurance, technical writing, usability engineering, and systems engineering at Datex-Ohmeda / GE Healthcare. Roles with increasing responsibility in project management and functional management followed at GE Healthcare and Baxter Healthcare. Most recently, Barb worked for Spacelabs Healthcare where she was the Director of Engineering for the Anesthesia business. Her strengths in team building, change management, and aligning groups to focus and execute per defined plans has resulted in several successful product releases and organizational changes.
Education: Barb holds a B.S. in Biology from the University of Minnesota, a B.S. in Biomedical Engineering from Milwaukee School of Engineering, and a Master’s in Business Administration from the University of Wisconsin – Whitewater. In addition, she is a certified Project Management Professional (PMP).
Bio: Lisa has more than 30 years of sales and marketing leadership experience in the medical imaging industry. She was most recently Senior Director of Marketing at Navidea Biopharmaceuticals, where she held key roles in the successful launch and growth of its oncology diagnostic radiopharmaceutical, from initial FDA approval through several expanded indications. Prior to that, she held roles of increasing marketing and sales responsibility in the cardiology and oncology franchises of Bristol-Myers Squibb Medical Imaging and The DuPont Pharmaceutical Company, among others. Lisa has a proven ability to launch, grow and support clinically complex products and deep experience in the nuclear medicine industry. Her strengths in developing, motivating and empowering sales teams and her expertise in applying in-depth clinical knowledge when communicating with customers make her a key asset to the NorthStar management team.
Education: Lisa received her Bachelor of Arts degree in biology from the Massachusetts College of Liberal Arts.
Bio: Stu has worked in the pharmaceutical and medical device industry for more than 20 years. His regulatory and legal expertise include promotion and advertising, current good manufacturing practice, product labeling, drug and device safety, product recalls and other field actions, good clinical practice, quality assurance, regulatory inspections, product life cycle management, trade compliance, and Proposition 65. Stu comes to NorthStar from Cardinal Health, where he served as Vice President and Associate General Counsel, Regulatory. Previously, he has worked as in-house regulatory counsel for Mallinckrodt, Covidien, Cephalon, and Abbott Laboratories. Stu also was an associate in the law firm of McKenna, Long & Aldridge and served as a research analyst for the National Bioethics Advisory Commission (NBAC).
Education: Stu earned his J.D. from the University of Wisconsin Law School. He also holds an M.S. in Anatomy from the University of Wisconsin-Madison, an M.S. in Biological Sciences from the University of Notre Dame, and a B.S. in Biology (with honors) from Lafayette College.
Bio: Rim has more than 30 years of engineering experience encompassing medical devices, mobile devices and automotive control systems, as well as extensive knowledge in hardware and software engineering. He comes to NorthStar from Baxter International Inc., where he was Senior Director, Global Product Management for the company’s infusion systems business. Before that, he served as Director, Program Management – New Product Development for Baxter’s renal business. Prior to joining Baxter, he worked for Motorola Mobile Devices, Motorola Automotive and Industrial Electronics Group, Tenneco Corporation and General Motors Company’s Saturn Corporation subsidiary.
Education: Rim earned a Master of Business Administration degree from the University of Michigan and a Bachelor of Science degree in Mechanical Engineering from the University of Illinois.
Bio: Darcy brings 30 years of Operational expertise to NorthStar where she is responsible for the Company’s Instrument Manufacturing Operations including Customer Care, Supply Chain, Production, and Shipping to nuclear pharmacies. Prior to coming to NorthStar, she was Materials Manager for a contract manufacturer where she led the development and implementation of lean materials practices and production scheduling to support quick turn-around to ensure customer satisfaction. Previously, she was Director of Materials at Burdick/Spacelabs/Quinton Cardiology, a manufacturer of cardiac testing and rehabilitation systems. Prior to that, she was Materials Manager with Marquip, where she established its materials department from inception. Darcy began her career in Materials at Norland Corporation which manufactured external programming instruments for pacemakers. In her progression from Buyer to Director of Operations, Darcy held increasingly responsible positions. Her comprehensive skill set in all aspects of operations provides a valuable resource for NorthStar.
Education: Darcy graduated from Madison Area Technical College in Madison, Wisconsin.
Bio: Rob has 29 years of experience encompassing roles in quality, manufacturing, and research and development at in-vitro diagnostic, medical device, and pharmaceutical companies. He comes to NorthStar from Avantor, where he was the Vice President of Quality and Compliance Systems and Services. Before that, he served as the Director, Global Quality Risk Management at Thermo Fisher Scientific. Prior to joining Thermo Fisher Scientific, he worked for AbbVie, Pricewaterhouse Coopers, Pfizer, Baxter, and Abbott Laboratories.
Education: Rob earned a Bachelor of Science degree in Biology from the University of Wisconsin – Stevens Point.
Bio: Dave brings 30 years of radiopharmaceutical manufacturing leadership experience to NorthStar. His expertise in creating and implementing successful operational programs in rapidly growing radiopharmaceutical businesses provides a valuable resource for the Company. Prior to joining NorthStar, Dave was Vice President, PET & SPECT Pharmacy Operations for Triad Isotopes, where he oversaw daily operations of its southeastern U.S. radiopharmacies. In addition, he led all its PET manufacturing sites through several FDA approvals, including F-18 FDG and F-18 NaF. Previously, while at PETNET Solutions, a Siemens company, Dave led multi-disciplinary teams in a dynamic growth environment to establish new PET isotope manufacturing centers across the United States. Dave’s ability to effectively lead diverse functional teams, in addition to his financial skills focused on operational efficiency, are a welcome addition to the NorthStar management team.
Education: Dave is a Board Certified Nuclear Pharmacist and holds a Bachelor of Science in Pharmacy from the St Louis College of Pharmacy.
Bio: George is Chairman Emeritus of NorthStar Medical Radioisotopes, LLC, and founder of NorthStar Medical Technologies, which holds several leading technology subsidiaries including NorthStar Medical Radioisotopes. With 30 years of executive experience in the medical industry in roles of CEO or COO, George brings a proven leadership skill set to NorthStar. His expertise encompasses acquisition and development of core technologies, forging relationships with universities and national labs and creation of international joint ventures for the manufacturing and distribution of medical equipment. George has raised more than $200 million in financings to support companies he has acquired and/or technologies he has licensed/acquired. In addition, George has secured $50 million in financial grants from the U.S. Department of Energy in support of NorthStar’s Mo99 program. Businesses under George’s leadership have provided annual compounded investor returns of more than 40 percent. Additionally, George has worked closely with the U.S. Department of Defense, obtaining a Top Secret Clearance from the US Government in support of projects such as the Fire Control, Radar and Missile Systems on-board U.S. destroyers, the Airborne Warning and Control System (AWACS) Program, the Delta rocket and the Viking Lander Programs.
Education: George received his BS degree in Electrical Engineering from New Jersey Institute of Technology
James (Jim) Brodack joined NorthStar on August 15, 2016 as Vice President of Regulatory and Quality Affairs. He was promoted to Senior Vice President and Chief Regulatory Officer on September 10, 2018. Sadly, he passed away on March 27, 2021. Jim had worked in the pharmaceutical industry for more than 30 years, holding multiple management positions with leading medical companies. He came to NorthStar from Guerbet, where he served as Director of Regulatory Affairs for the company’s Liebel-Flarsheim Company LLC business. Prior to that, he worked for Mallinckrodt Pharmaceuticals’ imaging business for 25 years, holding a series of increasingly responsible positions in both regulatory affairs and research and development. Before joining Mallinckrodt, he held several academic posts at Washington University in St. Louis, pursuing research interests involving positron-emitting radiopharmaceuticals and the use of robotics to automate radiopharmaceutical production.
Jim was a passionate supporter of NorthStar’s business who, with his deep knowledge and experience of radioisotopes and Regulatory Affairs, was able to guide the company successfully through an extremely complex NDA submission, multiple FDA inspections and multiple supplemental submissions. At the same time, he gave exceptionally insightful strategic advice relating to regulatory matters, and this advice has ensured that many of the ongoing and future projects have started out with clear regulatory direction and high probability of success. Jim also built a capable Regulatory Affairs team and provided them with the coaching and technical knowledge required for their future success. Jim’s contributions at Board Meetings, Leadership Team Meetings and many other cross-functional meetings were always valuable and focused on ensuring solutions were in NorthStar’s best interests.
Our deepest condolences go out to Jim’s wife Susan, and his three sons – Adam, Cory and Dale.
Diane M. Hendricks has served on NorthStar’s Board of Managers since 2010 and was appointed Chairperson in 2018. Diane is also the Chairperson and sole shareholder of ABC Supply Co. Inc. ABC Supply is the largest wholesale distributor of exterior building products in the United States with more than 700 locations nationwide, 14,000 associates, and projected sales for 2018 of $10 billion. Diane and her late husband, Kenneth Hendricks, founded ABC Supply in 1982.
Through the ownership of Hendricks Commercial Properties, Diane is the owner of a large national portfolio of industrial and commercial real estate. Diane is also Chairperson of Hendricks Holding Company, Inc. (“HHC”), a holding company that includes a diverse portfolio of companies in manufacturing, service and distribution industries, including NorthStar Medical Technologies LLC (“NorthStar”). HHC is currently the majority shareholder in NorthStar.
Jon Coulter is Managing Director at Hendricks Holding Company, Inc. (“HHC”) and has responsibility for several HHC portfolio companies, including NorthStar Medical Technologies LLC. Jon has served on NorthStar’s Board of Managers since 2010. Before joining HHC, Jon was an investment banker at Robert W. Baird & Co. (“Baird”) and a Principal at Baird Capital Partners, the private equity arm of Baird. Jon also was an investment banker at Cleary Gull, Inc
Jon served twelve years in the U.S. Air Force as an Operations Staff Officer and Instructor Pilot, and is a veteran of Operation Desert Storm. He earned a Bachelor of Science from Purdue University and an M.B.A. from the University of Wisconsin – Madison.
Randy has served as a Board Member of NorthStar since 2012. He led an investment group that supported NorthStar’s early development and has continued to invest in the growth of NorthStar’s industry leading technology. Randy is a food industry veteran with two decades of senior executive leadership at Kerry plc, where he gained extensive experience of compliance with FDA regulations. In retirement he continues to be active in the food industry through consulting and Board roles, which has enabled him to keep current of industry dynamics and FDA policy. He has been a leader and active member of Stateline Angels, who have invested over $10M in 20 companies during the last decade.
Steve, appointed as President and Chief Executive Officer of NorthStar in September 2018, has more than 25 years of experience in the biotechnology, pharmaceutical and life sciences industries . He has held multiple executive positions with leading multinational companies, including leadership of nuclear medicine businesses. Steve has extensive general management and corporate officer experience, and a proven record of accomplishment with integrating science, engineering and commercial activities to drive complex projects to successful completion. Steve also served in the Royal Navy as a Nuclear Submarine Officer, where he specialized in Navigation and Operations.
Steve received a BSc (Honors) in Engineering Science from the University of Exeter and an MBA from the London Business School, both in the United Kingdom. He also completed the Nuclear General Course at the Royal Naval Staff College, Greenwich in the United Kingdom.
Paul brings more than 30 years of relevant experience to NorthStar where he is responsible for the Financial operations of the company. Prior to NorthStar, he was the CFO of Melinta Therapeutics, Inc., a publicly traded company focused on the discovery, development and commercialization of novel antibiotics. During his five-year tenure at Melinta, Paul guided the company in the process of converting from a private to public enterprise, raised more than $500 million in support of the company, assisted in the acquisition of products from other companies, facilitated a merger and supported the commercial launch of multiple products. Prior to Melinta, he spent more than 20 years with Baxter International, Inc. where he held both financial and non-financial positions of increasing responsibility. During his tenure at Baxter, his experiences included divisional CFO for various divisions of Baxter, CFO of Baxter’s operations in Japan and serving as the Vice-President of Integration for a large acquisition. Prior to Baxter, Paul was a public accountant with Arthur Andersen & Co.
Paul earned a Master of Business Administration degree from the Kellogg School of Management at Northwestern University and a Bachelor of Science degree in Accounting from Illinois State University.